Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | (S)-nicotine | increases expression | ISO | Vamp4 (Mus musculus) | 6480464 | Nicotine results in increased expression of VAMP4 mRNA | CTD | PMID:17997037 | 1,2-dimethylhydrazine | decreases expression | ISO | Vamp4 (Mus musculus) | 6480464 | 1 and 2-Dimethylhydrazine results in decreased expression of VAMP4 mRNA | CTD | PMID:22206623 | 2,2',4,4'-Tetrabromodiphenyl ether | increases expression | EXP | | 6480464 | 2 more ... | CTD | PMID:19095052 | 2,2',4,4'-Tetrabromodiphenyl ether | affects expression | ISO | Vamp4 (Mus musculus) | 6480464 | 2 more ... | CTD | PMID:30294300 | 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | ISO | Vamp4 (Mus musculus) | 6480464 | AHR protein inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of VAMP4 mRNA] | CTD | PMID:15034205 | 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | Vamp4 (Mus musculus) | 6480464 | Tetrachlorodibenzodioxin results in increased expression of VAMP4 mRNA | CTD | PMID:15034205 | 2-hydroxypropanoic acid | decreases expression | EXP | | 6480464 | Lactic Acid results in decreased expression of VAMP4 mRNA | CTD | PMID:30851411 | 3-isobutyl-1-methyl-7H-xanthine | multiple interactions | EXP | | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of VAMP4 mRNA and [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of VAMP4 mRNA | CTD | PMID:28628672 | 6-propyl-2-thiouracil | decreases expression | ISO | Vamp4 (Rattus norvegicus) | 6480464 | Propylthiouracil results in decreased expression of VAMP4 mRNA | CTD | PMID:30047161 | aflatoxin B1 | increases expression | ISO | Vamp4 (Mus musculus) | 6480464 | Aflatoxin B1 results in increased expression of VAMP4 mRNA | CTD | PMID:19770486 | amitrole | decreases expression | ISO | Vamp4 (Rattus norvegicus) | 6480464 | Amitrole results in decreased expression of VAMP4 mRNA | CTD | PMID:30047161 | arsenite(3-) | multiple interactions | EXP | | 6480464 | arsenite promotes the reaction [G3BP1 protein binds to VAMP4 mRNA] | CTD | PMID:32406909 | arsenous acid | increases expression | EXP | | 6480464 | Arsenic Trioxide results in increased expression of VAMP4 mRNA | CTD | PMID:20458559 | benzo[a]pyrene | multiple interactions | ISO | Vamp4 (Mus musculus) | 6480464 | AHR protein inhibits the reaction [Benzo(a)pyrene results in increased expression of VAMP4 mRNA] | CTD | PMID:15034205 | benzo[a]pyrene | increases expression | ISO | Vamp4 (Mus musculus) | 6480464 | Benzo(a)pyrene results in increased expression of VAMP4 mRNA | CTD | PMID:15034205 and PMID:22228805 | bisphenol A | affects expression | ISO | Vamp4 (Rattus norvegicus) | 6480464 | bisphenol A affects the expression of VAMP4 mRNA | CTD | PMID:25181051 | bisphenol A | decreases expression | ISO | Vamp4 (Mus musculus) | 6480464 | bisphenol A results in decreased expression of VAMP4 mRNA | CTD | PMID:33221593 | bisphenol A | multiple interactions | EXP | | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of VAMP4 mRNA | CTD | PMID:28628672 | bisphenol F | multiple interactions | EXP | | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of VAMP4 mRNA | CTD | PMID:28628672 | butanal | decreases expression | EXP | | 6480464 | butyraldehyde results in decreased expression of VAMP4 mRNA | CTD | PMID:26079696 | cadmium atom | multiple interactions | EXP | | 6480464 | [Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of VAMP4 mRNA | CTD | PMID:35301059 | cadmium dichloride | multiple interactions | EXP | | 6480464 | [Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of VAMP4 mRNA | CTD | PMID:35301059 | carbon nanotube | decreases expression | ISO | Vamp4 (Mus musculus) | 6480464 | Nanotubes more ... | CTD | PMID:25554681 | carmustine | affects response to substance | EXP | | 6480464 | VAMP4 mRNA affects the susceptibility to Carmustine | CTD | PMID:16365179 | CGP 52608 | multiple interactions | EXP | | 6480464 | CGP 52608 promotes the reaction [RORA protein binds to VAMP4 gene] | CTD | PMID:28238834 | cisplatin | decreases expression | EXP | | 6480464 | Cisplatin results in decreased expression of VAMP4 mRNA | CTD | PMID:27392435 | cobalt dichloride | increases expression | EXP | | 6480464 | cobaltous chloride results in increased expression of VAMP4 mRNA | CTD | PMID:19376846 | copper(II) sulfate | decreases expression | EXP | | 6480464 | Copper Sulfate results in decreased expression of VAMP4 mRNA | CTD | PMID:19549813 | cyclosporin A | increases expression | EXP | | 6480464 | Cyclosporine results in increased expression of VAMP4 mRNA | CTD | PMID:20106945 more ... | deoxynivalenol | increases expression | EXP | | 6480464 | deoxynivalenol results in increased expression of VAMP4 mRNA | CTD | PMID:23792671 | dexamethasone | multiple interactions | EXP | | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of VAMP4 mRNA and [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of VAMP4 mRNA | CTD | PMID:28628672 | diarsenic trioxide | increases expression | EXP | | 6480464 | Arsenic Trioxide results in increased expression of VAMP4 mRNA | CTD | PMID:20458559 | dicrotophos | decreases expression | EXP | | 6480464 | dicrotophos results in decreased expression of VAMP4 mRNA | CTD | PMID:28302478 | disodium selenite | decreases expression | EXP | | 6480464 | Sodium Selenite results in decreased expression of VAMP4 mRNA | CTD | PMID:18175754 | epoxiconazole | increases expression | ISO | Vamp4 (Mus musculus) | 6480464 | epoxiconazole results in increased expression of VAMP4 mRNA | CTD | PMID:35436446 | ethanol | multiple interactions | ISO | Vamp4 (Mus musculus) | 6480464 | Ethanol affects the expression of and affects the splicing of VAMP4 mRNA | CTD | PMID:30319688 | ethyl methanesulfonate | increases expression | EXP | | 6480464 | Ethyl Methanesulfonate results in increased expression of VAMP4 mRNA | CTD | PMID:23649840 | flutamide | decreases expression | ISO | Vamp4 (Rattus norvegicus) | 6480464 | Flutamide results in decreased expression of VAMP4 mRNA | CTD | PMID:24136188 | formaldehyde | increases expression | EXP | | 6480464 | Formaldehyde results in increased expression of VAMP4 mRNA | CTD | PMID:23649840 | FR900359 | increases phosphorylation | EXP | | 6480464 | FR900359 results in increased phosphorylation of VAMP4 protein | CTD | PMID:37730182 | hexadecanoic acid | multiple interactions | EXP | | 6480464 | [Palmitic Acid co-treated with Oleic Acid co-treated with TNF protein] affects the expression of VAMP4 mRNA and [Palmitic Acid co-treated with Oleic Acid] affects the expression of VAMP4 mRNA | CTD | PMID:30547786 | indometacin | multiple interactions | EXP | | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of VAMP4 mRNA and [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of VAMP4 mRNA | CTD | PMID:28628672 | methapyrilene | decreases expression | ISO | Vamp4 (Rattus norvegicus) | 6480464 | Methapyrilene results in decreased expression of VAMP4 mRNA | CTD | PMID:30467583 | methidathion | increases expression | ISO | Vamp4 (Mus musculus) | 6480464 | methidathion results in increased expression of VAMP4 mRNA | CTD | PMID:34813904 | methyl methanesulfonate | increases expression | EXP | | 6480464 | Methyl Methanesulfonate results in increased expression of VAMP4 mRNA | CTD | PMID:23649840 | methylazoxymethanol | increases expression | ISO | Vamp4 (Mus musculus) | 6480464 | methylazoxymethanol results in increased expression of VAMP4 mRNA | CTD | PMID:17107856 | methylmercury chloride | decreases expression | EXP | | 6480464 | methylmercuric chloride results in decreased expression of VAMP4 mRNA | CTD | PMID:28001369 | niclosamide | increases expression | EXP | | 6480464 | Niclosamide results in increased expression of VAMP4 mRNA | CTD | PMID:36318118 | nicotine | increases expression | ISO | Vamp4 (Mus musculus) | 6480464 | Nicotine results in increased expression of VAMP4 mRNA | CTD | PMID:17997037 | oleic acid | multiple interactions | EXP | | 6480464 | [Palmitic Acid co-treated with Oleic Acid co-treated with TNF protein] affects the expression of VAMP4 mRNA and [Palmitic Acid co-treated with Oleic Acid] affects the expression of VAMP4 mRNA | CTD | PMID:30547786 | pentanal | decreases expression | EXP | | 6480464 | pentanal results in decreased expression of VAMP4 mRNA | CTD | PMID:26079696 | phenobarbital | affects expression | EXP | | 6480464 | Phenobarbital affects the expression of VAMP4 mRNA | CTD | PMID:19159669 | rac-lactic acid | decreases expression | EXP | | 6480464 | Lactic Acid results in decreased expression of VAMP4 mRNA | CTD | PMID:30851411 | silicon dioxide | decreases expression | ISO | Vamp4 (Mus musculus) | 6480464 | Silicon Dioxide results in decreased expression of VAMP4 mRNA | CTD | PMID:19073995 | sodium arsenite | decreases expression | EXP | | 6480464 | sodium arsenite results in decreased expression of VAMP4 mRNA | CTD | PMID:28595984 and PMID:34032870 | Soman | increases expression | ISO | Vamp4 (Rattus norvegicus) | 6480464 | Soman results in increased expression of VAMP4 mRNA | CTD | PMID:19281266 | sulfadimethoxine | decreases expression | ISO | Vamp4 (Rattus norvegicus) | 6480464 | Sulfadimethoxine results in decreased expression of VAMP4 mRNA | CTD | PMID:30047161 | temozolomide | affects response to substance | EXP | | 6480464 | VAMP4 mRNA affects the susceptibility to temozolomide | CTD | PMID:16365179 | thioacetamide | decreases expression | ISO | Vamp4 (Rattus norvegicus) | 6480464 | Thioacetamide results in decreased expression of VAMP4 mRNA | CTD | PMID:23411599 | triptonide | affects expression | ISO | Vamp4 (Mus musculus) | 6480464 | triptonide affects the expression of VAMP4 mRNA | CTD | PMID:33045310 | tunicamycin | increases expression | EXP | | 6480464 | Tunicamycin results in increased expression of VAMP4 mRNA | CTD | PMID:22378314 | valproic acid | increases expression | EXP | | 6480464 | Valproic Acid results in increased expression of VAMP4 mRNA | CTD | PMID:29154799 | valproic acid | affects expression | EXP | | 6480464 | Valproic Acid affects the expression of VAMP4 mRNA | CTD | PMID:25979313 | valproic acid | decreases expression | EXP | | 6480464 | Valproic Acid results in decreased expression of VAMP4 mRNA | CTD | PMID:23179753 | valproic acid | affects expression | ISO | Vamp4 (Mus musculus) | 6480464 | Valproic Acid affects the expression of VAMP4 mRNA | CTD | PMID:17963808 | zinc atom | decreases expression | EXP | | 6480464 | Zinc deficiency results in decreased expression of VAMP4 mRNA | CTD | PMID:22171008 | zinc(0) | decreases expression | EXP | | 6480464 | Zinc deficiency results in decreased expression of VAMP4 mRNA | CTD | PMID:22171008 | |